Background In people who are infected with the hepatitis C virus (HCV), chronic infection
often develops and is difficult to eradicate. We sought to determine whether treatment during …

Acute hepatitis C takes a chronic course in 50–80% of cases. Results with interferon
treatment are conflicting. To evaluate the efficacy of high-dose interferon treatment, we …

Early treatment of acute hepatitis C infection with interferon alfa‐2b (IFN‐α‐2b) prevents
chronicity in almost all patients. So far, no data are available on the long‐term outcome after …

Background: Appropriate treatment of acute hepatitis C is still a matter of controversy due to
the lack of large controlled trials. Aim: To assess the effectiveness of interferon as treatment …

Acute hepatitis C often progresses to chronic infection. We undertook a randomized
controlled trial to determine whether short‐term therapy with interferon (IFN) during acute …

The efficacy of short-course (three months), low-dose (3 million units three times a week)
interferon as treatment for acute hepatitis C was evaluated in a meta-analysis of controlled …

Abstract Background/Aims: Non-A, non-B acute hepatitis progresses to a higher incidence of
chronicity and hepatocellular carcinoma. To avoid the development of chronic liver disease …

Diagnosing acute hepatitis C is still difficult. The disease is frequently asymptomatic and
there are no specific diagnostic tests. Most frequently, diagnosis is based on anti HCV …

Acute hepatitis C has a high propensity to become chronic, which provides the rationale for
treating patients with acute disease attempting to prevent chronicity. Almost all published …

Early treatment of acute hepatitis C with interferon alpha‐2b for 24 weeks prevents chronic
infection in almost all patients. Because pegylated interferons have replaced conventional …